All News

My visits to the local cancer center were very impactful as a cancer survivor, and I consider that staff a part of my family.

A decade after becoming a bone marrow donor following his brother’s diagnosis of myelofibrosis, former “Queer Eye for the Straight Guy” co-star Thom Filicia is one of the partners behind the Mapping Myelofibrosis initiative.

The Food and Drug Administration approved Augtyro for patients with ROS1-positive metastatic non-small cell lung cancer based on a phase 1/2 trial.

An expert discusses why patients with melanoma may undergo treatment even after their tumor was surgically removed, and how melanoma became the “poster child” for immunotherapy.

Patients with colorectal cancer who had diabetes with complications had an 85% higher risk of death than those without diabetes, according to the findings of a study.

CURE® spoke with the director of oncology pharmacy at Massachusetts General Hospital about recent cancer drug shortages that have been making headlines.

It’s been more than half a year since I rang the bell at the hospital signaling that I was free of non-Hodgkins Lymphoma.

Keytruda plus chemotherapy for patients with locally advanced biliary tract cancer helped increase survival for up to two more years, an expert told CURE®.

Where I grew up, cancer was not openly discussed.

Stereotactic radiation is promising in treating patients with metastatic kidney cancer and may delay the time until patients need further treatment, an expert said.

A multidisciplinary surgical approach decreased death rates by 70% in patients with ovarian cancer.

My diagnosis of prostate cancer gave me an unsuspected gift.

Patients who had low levels of vitamin D before starting chemotherapy tended to have higher rates of chemotherapy-induced peripheral neuropathy, but more research is needed in this field.

Here are ways to become a patient advocate.

Patients with advanced clear cell renal cell carcinoma treated with zanzalintinib had experienced promising antitumor activity with manageable toxicity regardless of prior treatment with cabozantinib.

Researchers continue to investigate novel immunotherapy drugs for the treatment of renal cell carcinoma.

After receiving a cancer diagnosis, it stays with you 24/7.

While CAR-T cell therapy is showing promise in treating patients with advanced renal cell carcinoma, there is still more research that needs to be done in this arena.

Although research has delved into the potential link between clonal hematopoiesis and heart-related events such as heart attacks and strokes in patients with kidney cancer, more research is needed to further understand this association.

Older adults with late stage cancer often prioritize quality of life and independence over survival time, which may change their treatment plan, an expert said.

I was in denial after the shock of being told I had prostate cancer.

Circulating tumor DNA — which is observed via blood test — may be helpful in determining which patients with kidney cancer need more intense treatment and who can have their therapies deescalated.

Last week’s oncology headlines focused on veterans with cancer, as well as FDA regulatory decisions and an expert’s opinion on what patients need to consider when choosing a Medicare plan.

Researchers found that some caregivers face racism and discrimination as they care for loved ones with cancer.

Most patients with cancer may not be discussing the cost of care with their clinicians, according to recent research.

Patients with prostate cancer who receive docetaxel with standard-of-care treatment may have a reduced risk of death and an improved prognosis, according to a recent study.

Up to a quarter of patients with breast cancer face financial burden due to the cost of supplements, complimentary therapy and alternative medicines which “may decrease adherence to prescribed medications,” researchers found.

A phase 3 trial found that testosterone recovery after androgen deprivation therapy leads to better quality of life following high-risk prostate cancer.

While translocation renal cell carcinoma tends to respond well to immunotherapy, there is still a need for more investigation into targeted therapies for this patient population.